These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Recurrent intrahepatic cholestasis of pregnancy: ursodeoxycholic acid should be the first line of treatment. Jain P J Gastrointestin Liver Dis; 2008 Dec; 17(4):479-80. PubMed ID: 19104716 [No Abstract] [Full Text] [Related]
29. Toward precision medicine in primary biliary cholangitis. Carbone M; Ronca V; Bruno S; Invernizzi P; Mells GF Dig Liver Dis; 2016 Aug; 48(8):843-50. PubMed ID: 27324985 [TBL] [Abstract][Full Text] [Related]
30. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver]. Golovanova EV; Petrakov AV Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847 [TBL] [Abstract][Full Text] [Related]
31. Jeune syndrome and liver disease: report of three cases treated with ursodeoxycholic acid. Labrune P; Fabre M; Trioche P; Estournet-Mathiaud B; Grangeponte MC; Rambaud C; Maurage C; Bernard O Am J Med Genet; 1999 Dec; 87(4):324-8. PubMed ID: 10588838 [TBL] [Abstract][Full Text] [Related]
32. The relative expression of hepatocellular and cholestatic liver enzymes in adult patients with liver disease. Iluz-Freundlich D; Zhang M; Uhanova J; Minuk GY Ann Hepatol; 2020; 19(2):204-208. PubMed ID: 31628070 [TBL] [Abstract][Full Text] [Related]
33. Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase. Murillo Perez CF; Harms MH; Lindor KD; van Buuren HR; Hirschfield GM; Corpechot C; van der Meer AJ; Feld JJ; Gulamhusein A; Lammers WJ; Ponsioen CY; Carbone M; Mason AL; Mayo MJ; Invernizzi P; Battezzati PM; Floreani A; Lleo A; Nevens F; Kowdley KV; Bruns T; Dalekos GN; Gatselis NK; Thorburn D; Trivedi PJ; Verhelst X; Parés A; Janssen HLA; Hansen BE; Am J Gastroenterol; 2020 Jul; 115(7):1066-1074. PubMed ID: 32618657 [TBL] [Abstract][Full Text] [Related]
35. [Ursodeoxycholic acid treatment in intrahepatic cholestasis of pregnancy. A case report]. Lengyel G; Fehér R; Gardó S; Fehér J Orv Hetil; 2002 Dec; 143(52):2885-8. PubMed ID: 12638316 [TBL] [Abstract][Full Text] [Related]
36. Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases. Trauner M; Graziadei IW Aliment Pharmacol Ther; 1999 Aug; 13(8):979-96. PubMed ID: 10468672 [TBL] [Abstract][Full Text] [Related]
37. Effect of ursodeoxycholic acid on chronic intrahepatic cholestasis due to sarcoidosis. Bécheur H; Dall'osto H; Chatellier G; Charton-Bain MC; Aubertin JM; Attar A; Bloch F; Petite JP Dig Dis Sci; 1997 Apr; 42(4):789-91. PubMed ID: 9125650 [No Abstract] [Full Text] [Related]